Literature DB >> 12821495

Activity of telithromycin against penicillin-resistant Streptococcus pneumoniae isolates recovered from French children with invasive and noninvasive infections.

Edouard Bingen1, Catherine Doit, Chawki Loukil, Naima Brahimi, Philippe Bidet, Dominique Deforche, Pierre Geslin.   

Abstract

We compared the activities of telithromycin, erythromycin, azithromycin, josamycin, penicillin G, amoxicillin, cefpodoxime, and ceftriaxone against invasive and noninvasive non-penicillin-susceptible Streptococcus pneumoniae isolates recovered from children. Of the 186 isolates tested, 89% were positive for erm(B) by PCR. Telithromycin had the lowest MICs, with MICs at which 90% of the isolates tested are inhibited of 0.032 and 0.25 micro g/ml for erythromycin-sensitive and -resistant isolates, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12821495      PMCID: PMC161828          DOI: 10.1128/AAC.47.7.2345-2347.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Mechanisms of macrolide resistance in clinical pneumococcal isolates in France.

Authors:  F Fitoussi; C Doit; P Geslin; N Brahimi; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

Authors:  G V Doern; K P Heilmann; H K Huynh; P R Rhomberg; S L Coffman; A B Brueggemann
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Antipneumococcal activity of ABT-773 compared to those of 10 other agents.

Authors:  T A Davies; L M Ednie; D M Hoellman; G A Pankuch; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

4.  Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis.

Authors:  E O Mason; L B Lamberth; N L Kershaw; B L Prosser; A Zoe; P G Ambrose
Journal:  J Antimicrob Chemother       Date:  2000-05       Impact factor: 5.790

5.  Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin.

Authors:  C Fogarty; R Goldschmidt; K Bush
Journal:  Clin Infect Dis       Date:  2000-08       Impact factor: 9.079

6.  Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin.

Authors:  M A Kelley; D J Weber; P Gilligan; M S Cohen
Journal:  Clin Infect Dis       Date:  2000-10-13       Impact factor: 9.079

7.  Macrolide resistance phenotypes and genotypes in French clinical isolates of Streptococcus pneumoniae. Observatoire de Normandie du Pneumocoque.

Authors:  P Angot; M Vergnaud; M Auzou; R Leclercq
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-10       Impact factor: 3.267

8.  Pharmacokinetics of the new ketolide telithromycin (HMR 3647) administered in ascending single and multiple doses.

Authors:  F Namour; D H Wessels; M H Pascual; D Reynolds; E Sultan; B Lenfant
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

9.  Detection of erythromycin-resistant determinants by PCR.

Authors:  J Sutcliffe; T Grebe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

Review 10.  Ketolides-telithromycin, an example of a new class of antibacterial agents.

Authors:  A Bryskier
Journal:  Clin Microbiol Infect       Date:  2000-12       Impact factor: 8.067

View more
  1 in total

1.  Streptococcus pneumoniae isolates resistant to telithromycin.

Authors:  M Rantala; M Haanperä-Heikkinen; M Lindgren; H Seppälä; P Huovinen; J Jalava
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.